Zioptan

tafluprost · Santen Oy

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zioptan, covering 2017-10-10 to 2018-07-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Tafluprost as an Adjunct to Medical Therapy for Residual Glaucoma After Trabeculectomy [NA]